181 related articles for article (PubMed ID: 11699963)
1. Oral and sub-cutaneous vaccination of commercial pigs with a recombinant porcine adenovirus expressing the classical swine fever virus gp55 gene.
Hammond JM; Jansen ES; Morrissy CJ; Williamson MM; Hodgson AL; Johnson MA
Arch Virol; 2001; 146(9):1787-93. PubMed ID: 11699963
[TBL] [Abstract][Full Text] [Related]
2. Protection of pigs against 'in contact' challenge with classical swine fever following oral or subcutaneous vaccination with a recombinant porcine adenovirus.
Hammond JM; Jansen ES; Morrissy CJ; Hodgson AL; Johnson MA
Virus Res; 2003 Nov; 97(2):151-7. PubMed ID: 14602208
[TBL] [Abstract][Full Text] [Related]
3. Classical swine fever (CSF) marker vaccine. Trial I. Challenge studies in weaner pigs.
Uttenthal A; Le Potier MF; Romero L; De Mia GM; Floegel-Niesmann G
Vet Microbiol; 2001 Nov; 83(2):85-106. PubMed ID: 11557151
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with a single dose of a recombinant porcine adenovirus expressing the classical swine fever virus gp55 (E2) gene protects pigs against classical swine fever.
Hammond JM; McCoy RJ; Jansen ES; Morrissy CJ; Hodgson AL; Johnson MA
Vaccine; 2000 Jan; 18(11-12):1040-50. PubMed ID: 10590324
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of intradermally administrated E2 subunit vaccines in reducing horizontal transmission of classical swine fever virus.
Dortmans JC; Loeffen WL; Weerdmeester K; van der Poel WH; de Bruin MG
Vaccine; 2008 Feb; 26(9):1235-42. PubMed ID: 18242794
[TBL] [Abstract][Full Text] [Related]
6. Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination.
de Smit AJ; Bouma A; de Kluijver EP; Terpstra C; Moormann RJ
Vet Microbiol; 2001 Feb; 78(4):307-17. PubMed ID: 11182497
[TBL] [Abstract][Full Text] [Related]
7. Glycoprotein E2 of classical swine fever virus expressed by baculovirus induces the protective immune responses in rabbits.
Zhang H; Li X; Peng G; Tang C; Zhu S; Qian S; Xu J; Qian P
Vaccine; 2014 Nov; 32(49):6607-13. PubMed ID: 25446823
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs.
Tarradas J; Argilaguet JM; Rosell R; Nofrarías M; Crisci E; Córdoba L; Pérez-Martín E; Díaz I; Rodríguez F; Domingo M; Montoya M; Ganges L
Vet Microbiol; 2010 Apr; 142(1-2):51-8. PubMed ID: 19896784
[TBL] [Abstract][Full Text] [Related]
9. Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs.
de Smit AJ; Bouma A; van Gennip HG; de Kluijver EP; Moormann RJ
Vaccine; 2001 Jan; 19(11-12):1467-76. PubMed ID: 11163670
[TBL] [Abstract][Full Text] [Related]
10. Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats.
Barrera M; Sánchez O; Farnós O; Rodríguez MP; Domínguez P; Tait H; Frías M; Avila M; Vega E; Toledo JR
Vet Immunol Immunopathol; 2010 Jan; 133(1):25-32. PubMed ID: 19640591
[TBL] [Abstract][Full Text] [Related]
11. Generation and Efficacy Evaluation of a Recombinant Pseudorabies Virus Variant Expressing the E2 Protein of Classical Swine Fever Virus in Pigs.
Wang Y; Yuan J; Cong X; Qin HY; Wang CH; Li Y; Li S; Luo Y; Sun Y; Qiu HJ
Clin Vaccine Immunol; 2015 Oct; 22(10):1121-9. PubMed ID: 26311244
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity in Swine of Orally Administered Recombinant Lactobacillus plantarum Expressing Classical Swine Fever Virus E2 Protein in Conjunction with Thymosin α-1 as an Adjuvant.
Xu YG; Guan XT; Liu ZM; Tian CY; Cui LC
Appl Environ Microbiol; 2015 Jun; 81(11):3745-52. PubMed ID: 25819954
[TBL] [Abstract][Full Text] [Related]
13. A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge.
Ganges L; Barrera M; Núñez JI; Blanco I; Frias MT; Rodríguez F; Sobrino F
Vaccine; 2005 May; 23(28):3741-52. PubMed ID: 15882536
[TBL] [Abstract][Full Text] [Related]
14. Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV.
van Gennip HG; Bouma A; van Rijn PA; Widjojoatmodjo MN; Moormann RJ
Vaccine; 2002 Feb; 20(11-12):1544-56. PubMed ID: 11858861
[TBL] [Abstract][Full Text] [Related]
15. A promising multiple-epitope recombinant vaccine against classical swine fever virus.
Tian H; Hou X; Wu J; Chen Y; Shang Y; Yin S; Zhang K; Liu X
Vet Immunol Immunopathol; 2014 Jan; 157(1-2):59-64. PubMed ID: 24269058
[TBL] [Abstract][Full Text] [Related]
16. Multiple linear B-cell epitopes of classical swine fever virus glycoprotein E2 expressed in E.coli as multiple epitope vaccine induces a protective immune response.
Zhou B; Liu K; Jiang Y; Wei JC; Chen PY
Virol J; 2011 Jul; 8():378. PubMed ID: 21801433
[TBL] [Abstract][Full Text] [Related]
17. Oral immunisation against classical swine fever (CSF): onset and duration of immunity.
Kaden V; Lange B
Vet Microbiol; 2001 Oct; 82(4):301-10. PubMed ID: 11506924
[TBL] [Abstract][Full Text] [Related]
18. Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2).
Voigt H; Merant C; Wienhold D; Braun A; Hutet E; Le Potier MF; Saalmüller A; Pfaff E; Büttner M
Vaccine; 2007 Aug; 25(31):5915-26. PubMed ID: 17600594
[TBL] [Abstract][Full Text] [Related]
19. Oral immunisation of swine with a classical swine fever vaccine (Chinese strain) and transmission studies in rabbits and sheep.
Chenut G; Saintilan AF; Burger C; Rosenthal F; Crucière C; Picard M; Bruyère V; Albina E
Vet Microbiol; 1999 Feb; 64(4):265-76. PubMed ID: 10063532
[TBL] [Abstract][Full Text] [Related]
20. Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV.
Maurer R; Stettler P; Ruggli N; Hofmann MA; Tratschin JD
Vaccine; 2005 May; 23(25):3318-28. PubMed ID: 15837238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
